Annals of Oncology, 1569-8041

Journal

More filtering options
  1. 2019
  2. Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

    Matikas, A., Foukakis, T., Moebus, V., Greil, R., Bengtsson, N. O., Steger, G. G., Untch, M., Johansson, H., Hellström, M., P. Malmström, Gnant, M., Loibl, S. & Bergh, J., 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, p. 109-114 6 p.

    Research output: Contribution to journalArticle

  3. Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment

    Weibring, K., Nord, C., Ståhl, O., J. Eberhard, Sandberg, K., Johansson, H., Arver, S., A. Giwercman & Cohn-Cedermark, G., 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 604-611 8 p.

    Research output: Contribution to journalArticle

  4. Vitamin B6 catabolism and lung cancer risk: Results from the Lung Cancer Cohort Consortium (LC3)

    Zuo, H., Ueland, P. M., Midttun, Tell, G. S., Fanidi, A., Zheng, W., Shu, X., Xiang, Y., Wu, J., Prentice, R., Pettinger, M., Thomson, C. A., Giles, G. G., Hodge, A., Cai, Q., Blot, W. J., Johansson, M., Hultdin, J., Grankvist, K., Stevens, V. L. & 29 othersMcCullough, M. L., Weinstein, S. J., Albanes, D., Ziegler, R. G., Freedman, N. D., Caporaso, N. E., Langhammer, A., Hveem, K., Næss, M., Buring, J. E., Lee, I., Gaziano, J. M., Severi, G., Zhang, X., Stampfer, M. J., Han, J., Zeleniuch-Jacquotte, A., Marchand, L. L., Yuan, J., Wang, R., Koh, W., Gao, Y., U. Ericson, Visvanathan, K., Jones, M. R., Relton, C., Brennan, P., Johansson, M. & Ulvik, A., 2019, In : Annals of Oncology. 30, 3, p. 478-485 8 p.

    Research output: Contribution to journalArticle

  5. 2018
  6. Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers

    Dominik Glodzik, Purdie, C. A., Rye, I. H., Simpson, P. T., Johan Staaf, Span, P. N., Russnes, H. & Nik-Zainal, S., 2018 Sep 15, In : Annals of Oncology. 30252041.

    Research output: Contribution to journalArticle

  7. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy

    Friedlander, M., Rau, J., Lee, C. K., Meier, W., Lesoin, A., Kim, J. W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M. T., Debruyne, P., Bologna, A., Malander, S., Monk, B. J., Petru, E., Calvert, P., Herzog, T. J., Barrett, C. & 1 othersdu Bois, A., 2018 Mar 1, In : Annals of Oncology. 29, 3, p. 737-743 7 p., mdx821.

    Research output: Contribution to journalArticle

  8. Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: The RASTEN trial

    Ek, L., E. Gezelius, Bergman, B., P. O. Bendahl, Anderson, H., Sundberg, J., Wallberg, M., Falkmer, U., Verma, S., M. Belting & Swedish Lung Cancer Study Group (SLUSG), 2018 Feb 1, In : Annals of Oncology. 29, 2, p. 398-404

    Research output: Contribution to journalArticle

  9. The genomic grade index predicts postoperative clinical outcome in patients with soft-tissue sarcoma

    Bertucci, F., De Nonneville, A., Finetti, P., Perrot, D., M. Nilbert, Italiano, A., Le Cesne, A., Skubitz, K. M., Blay, J. Y. & Birnbaum, D., 2018 Feb 1, In : Annals of Oncology. 29, 2, p. 459-465

    Research output: Contribution to journalArticle

  10. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

    Kwong, Y. L., Kim, S. J., Tse, E., Oh, S. Y., Kwak, J. Y., Eom, H. S., Do, Y. R., Mun, Y. C., Lee, S. R., Shin, H. J., Suh, C., Chuang, S. S., Lee, Y. S., Lim, S. T., Izutsu, K., Suzuki, R., Relander, T., d'Amore, F., Schmitz, N., Jaccard, A. & 1 othersKim, W. S., 2018 Jan 1, In : Annals of Oncology. 29, 1, p. 256-263 mdx684.

    Research output: Contribution to journalArticle

  11. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    ESMO Guidelines Committee, PaedCan, Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P. & 32 othersDhooge, C., M. Eriksson, Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I. & Merimsky, O., 2018, In : Annals of Oncology. 29, p. iv79-iv95

    Research output: Contribution to journalArticle

  12. 2017
  13. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Hochhaus, A., Saussele, S., Rosti, G., Mahon, F-X., Janssen, J. J. W. M., Hjorth-Hansen, H., J. Richter, Buske, C. & ESMO Guidelines Committee, 2017, In : Annals of Oncology. 28, p. iv41-iv51

    Research output: Contribution to journalArticle

  14. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Dreyling, M., Campo, E., Hermine, O., M. Jerkeman, Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., Ladetto, M. & on behalf of the ESMO Guidelines Committee, 2017, In : Annals of Oncology. 28, p. iv62-iv71

    Research output: Contribution to journalArticle

  15. 2016
  16. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

    Tandstad, T., Ståhl, O., Dahl, O., Haugnes, H. S., Håkansson, U., Karlsdottir, A., Kjellman, A., Langberg, C. W., Laurell, A., Oldenburg, J., Solberg, A., Söderström, K., Stierner, U., Cavallin-Ståhl, E., Wahlqvist, R., Wall, N. & Cohn-Cedermark, G., 2016 Jul 1, In : Annals of Oncology. 27, 7, p. 1299-1304 6 p., mdw164.

    Research output: Contribution to journalArticle

  17. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

    Helga Hagman, Frödin, J-E., Berglund, Å., Sundberg, J., Vestermark, L., Albertsson, M., Fernebro, E. & Anders Johnsson, 2016 Jan, In : Annals of Oncology. 27, 1, p. 140-147

    Research output: Contribution to journalArticle

  18. Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975.

    Boniol, M., Koechlin, A., Świątkowska, B., Sorahan, T., Wellmann, J., Taeger, D., Jakobsson, K., Pira, E., Boffetta, P., La Vecchia, C., Pizot, C. & Boyle, P., 2016, In : Annals of Oncology. 27, 5, p. 933-941

    Research output: Contribution to journalArticle

  19. 2015
  20. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

    Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., Calaminus, G., Capra, M., Deffenbaugh, C., Dhooge, C., Eriksson, M., Flanagan, A. M., Gelderblom, H., Goorin, A., Gorlick, R., Gosheger, G. & 21 othersGrimer, R. J., Hall, K. S., Helmke, K., Hogendoorn, P. C., Jundt, G., Kager, L., Kuehne, T., Lau, C., Letson, G. D., Meyer, J., Meyers, P., Morris, C., Mottl, H., Nadel, H., Nagarajan, R., Randall, R. L., Schomberg, P., Schwarz, R., Teot, L. A., Sydes, M. R. & Bernstein, M., 2015, In : Annals of Oncology. 26, 2, p. 407-414

    Research output: Contribution to journalArticle

  21. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

    Tobin, N. P., Harrell, J. C., Lovrot, J., Egyhazi Brage, S., Frostvik Stolt, M., Carlsson, L., Einbeigi, Z., Linderholm, B., Niklas Loman, Malmberg, M., Walz, T., Mårten Fernö, Perou, C. M., Bergh, J., Hatschek, T. & Lindstrom, L. S., 2015, In : Annals of Oncology. 26, 1, p. 81-88

    Research output: Contribution to journalArticle

  22. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Sophia Zackrisson & Cardoso, F., 2015, In : Annals of Oncology. 26, p. V8-V30

    Research output: Contribution to journalArticle

  23. 2014
  24. 32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.

    Siker Kimbung, Kovács, A., Johansson, I., Danielsson, A., Pär-Ola Bendahl, Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i11-i12

    Research output: Contribution to journalArticle

  25. 37p * androgen receptor expression in a population-based prospective breast cancer cohort.

    Karin Elebro, Signe Borgquist, Simonsson, M., Markkula, A., Carsten Rose, Christian Ingvar & Helena Jernström, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i13

    Research output: Contribution to journalPublished meeting abstract

  26. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype

    Fallah, M., Liu, X., Jianguang Ji, Asta Försti, Kristina Sundquist & Kari Hemminki, 2014, In : Annals of Oncology. 25, 7, p. 1397-1404

    Research output: Contribution to journalArticle

  27. One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.

    Tandstad, T., Ståhl, O., Håkansson, U., Dahl, O., Haugnes, H. S., Klepp, O. H., Langberg, C. W., Laurell, A., Oldenburg, J., Solberg, A., Söderström, K., Cavallin-Ståhl, E., Stierner, U., Wahlquist, R., Wall, N. & Cohn-Cedermark, G., 2014, In : Annals of Oncology. 25, 11, p. 2167-2172

    Research output: Contribution to journalArticle

  28. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

    Bonnefoi, H., Litiere, S., Piccart, M., MacGrogan, G., Fumoleau, P., Brain, E., Petit, T., Rouanet, P., Jassem, J., Moldovan, C., Bodmer, A., Zaman, K., Cufer, T., Campone, M., Luporsi, E., Per Malmström, Werutsky, G., Bogaerts, J., Bergh, J. & Cameron, D. A., 2014, In : Annals of Oncology. 25, 6, p. 1128-1136

    Research output: Contribution to journalArticle

  29. Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1): 9-15, 2014).

    Valentini, V., Abrahamsson, P-A., Aranda, S. K., Astier, A., Audisio, R. A., Boniol, M., Bonomo, L., Brunelli, A., Bultz, B., Chiti, A., De Lorenzo, F., Eriksen, J. G., Goh, V., Gospodarowicz, M. K., Grassi, L., Kelly, J., Kortmann, R. D., Kutluk, T., Plate, A., Poston, G. & 7 othersSaarto, T., Soffietti, R., Torresin, A., van Harten, W. H., Verzijlbergen, J. F., von Kalle, C. & Poortmans, P., 2014, In : Annals of Oncology. 25, 9, p. 1863-1865

    Research output: Contribution to journalLetter

  30. 2013
  31. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

    Anders Johnsson, Helga Hagman, Frödin, J-E., Berglund, Å., Keldsen, N., Fernebro, E., Sundberg, J., De Pont Christensen, R., Garm Spindler, K-L., Bergström, D. & Jakobsen, A., 2013, In : Annals of Oncology. 24, 9, p. 2335-2341

    Research output: Contribution to journalArticle

  32. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC)

    Fedirko, V., Trichopolou, A., Bamia, C., Duarte-Salles, T., Trepo, E., Aleksandrova, K., Noethlings, U., Lukanova, A., Lagiou, P., Boffetta, P., Trichopoulos, D., Katzke, V. A., Overvad, K., Tjonneland, A., Hansen, L., Boutron-Ruault, M. C., Fagherazzi, G., Bastide, N., Panico, S., Grioni, S. & 24 othersVineis, P., Palli, D., Tumino, R., Bueno-de-Mesquita, H. B., Peeters, P. H., Skeie, G., Engeset, D., Parr, C. L., Jakszyn, P., Sanchez, M. J., Barricarte, A., Amiano, P., Chirlaque, M., Quiros, J. R., Sund, M., Werner, M., Emily Sonestedt, Ulrika Ericson, Key, T. J., Khaw, K. T., Ferrari, P., Romieu, I., Riboli, E. & Jenab, M., 2013, In : Annals of Oncology. 24, 8, p. 2166-2173

    Research output: Contribution to journalArticle

  33. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

    Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trepo, E., Overvad, K., Roswall, N., Tjonneland, A., Boutron-Ruault, M. C., Fagherazzi, G., Racine, A., Kaaks, R., Grote, V. A., Boeing, H., Trichopoulou, A., Pantzalis, M., Kritikou, M., Mattiello, A., Sieri, S. & 21 othersSacerdote, C., Palli, D., Tumino, R., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quiros, J. R., Zamora-Ros, R., Sanchez, M. J., Arriola, L., Ardanaz, E., Tormo, M. J., Peter Nilsson, Lindkvist, B., Sund, M., Rolandsson, O., Khaw, K. T., Wareham, N., Travis, R. C., Riboli, E. & Noethlings, U., 2013, In : Annals of Oncology. 24, 9, p. 2449-2455

    Research output: Contribution to journalArticle

  34. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Obon-Santacana, M., Slimani, N., Lujan-Barroso, L., Travier, N., Hallmans, G., Freisling, H., Ferrari, P., Boutron-Ruault, M. C., Racine, A., Clavel, F., Saieva, C., Pala, V., Tumino, R., Mattiello, A., Vineis, P., Argueelles, M., Ardanaz, E., Amiano, P., Navarro, C., Sanchez, M. J. & 24 othersMontes, E. M., Key, T., Khaw, K. -T., Wareham, N., Peeters, P. H., Trichopoulou, A., Bamia, C., Trichopoulos, D., Boeing, H., Kaaks, R., Katzke, V., Ye, W., Sund, M., Ulrika Ericson, Elisabet Wirfält, Overvad, K., Tjonneland, A., Olsen, A., Skeie, G., Asli, L. A., Weiderpass, E., Riboli, E., Bueno-De-Mesquita, H. B. & Duell, E. J., 2013, In : Annals of Oncology. 24, 10, p. 2645-2651

    Research output: Contribution to journalArticle

  35. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

    Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M. -L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Janes, R., Pedersen, L. M., Anderson, H., Mats Jerkeman & Mikael Eriksson, 2013, In : Annals of Oncology. 24, 5, p. 1385-1392

    Research output: Contribution to journalArticle

  36. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.

    Tove Wästerlid, Brown, P. N., Oskar Hagberg, Hagberg, H., Pedersen, L. M., D'Amore, F. & Mats Jerkeman, 2013, In : Annals of Oncology. 24, 7, p. 1879-1886

    Research output: Contribution to journalArticle

  37. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Ståhl, E., Clarke, N. W., Classen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K. & 39 othersFlechon, A., Fossa, S. D., Germa Lluch, J. R., Gietema, J. A., Gillessen, S., Aleksander Giwercman, Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C. & Wittekind, C., 2013, In : Annals of Oncology. 24, 4, p. 878-888

    Research output: Contribution to journalReview article

  38. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Sophia Zackrisson & Cardoso, F., 2013, In : Annals of Oncology. 24, p. 7-23

    Research output: Contribution to journalArticle

  39. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  40. 2012
  41. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study

    Enblom, A., Anna Johnsson, Hammar, M., Onelov, E., Steineck, G. & Borjeson, S., 2012, In : Annals of Oncology. 23, 5, p. 1353-1361

    Research output: Contribution to journalArticle

  42. Adjuvant therapy in primary GIST: state-of-the-art

    Reichardt, P., Blay, J. -Y., Boukovinas, I., Brodowicz, T., Broto, J. M., Casali, P. G., Decatris, M., Mikael Eriksson, Gelderblom, H., Kosmidis, P., Le Cesne, A., Pousa, A. L., Schlemmer, M., Verweij, J. & Joensuu, H., 2012, In : Annals of Oncology. 23, 11, p. 2776-2781

    Research output: Contribution to journalReview article

  43. Autoimmune disease and subsequent digestive tract cancer by histology

    Kari Hemminki, Liu, X., Jianguang Ji, Jan Sundquist & Kristina Sundquist, 2012, In : Annals of Oncology. 23, 4, p. 927-U6

    Research output: Contribution to journalArticle

  44. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?

    Kari Hemminki, Bevier, M., Jan Sundquist & Hemminki, A., 2012, In : Annals of Oncology. 23, 10, p. 2720-2724

    Research output: Contribution to journalArticle

  45. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

    Schmitz, N., Zeynalova, S., Glass, B., Kaiser, U., Cavallin-Ståhl, E., Wolf, M., Haenel, M., Loeffler, M., Truemper, L. & Pfreundschuh, M., 2012, In : Annals of Oncology. 23, 5, p. 1267-1273

    Research output: Contribution to journalArticle

  46. Death causes in breast cancer patients

    Riihimaeki, M., Thomsen, H., Brandt, A., Jan Sundquist & Kari Hemminki, 2012, In : Annals of Oncology. 23, 3, p. 604

    Research output: Contribution to journalArticle

  47. First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG

    Lindemann, K., Christensen, R. D., Vergote, I., Stuart, G., Izquierdo, M. A., Kaem, J., Havsteen, H., Eisenhauer, E., Ridderheim, M., Lopez, A. B., Hirte, H., Aavall-Lundquvist, E., Vrdoljak, E., Green, J. & Kristensen, G. B., 2012, In : Annals of Oncology. 23, 10, p. 2613-U31

    Research output: Contribution to journalArticle

  48. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project

    Gonzalez, C. A., Megraud, F., Buissonniere, A., Lujan Barroso, L., Agudo, A., Duell, E. J., Boutron-Ruault, M. C., Clavel-Chapelon, F., Palli, D., Krogh, V., Mattiello, A., Tumino, R., Sacerdote, C., Quiros, J. R., Sanchez-Cantalejo, E., Navarro, C., Barricarte, A., Dorronsoro, M., Khaw, K. -T., Wareham, N. & 31 othersAllen, N. E., Tsilidis, K. K., Bueno-de-Mesquita, H. B., Jeurnink, S. M., Numans, M. E., Peeters, P. H. M., Lagiou, P., Valanou, E., Trichopoulou, A., Kaaks, R., Lukanova-McGregor, A., Bergman, M. M., Boeing, H., Jonas Manjer, Lindkvist, B., Stenling, R., Hallmans, G., Mortensen, L. M., Overvad, K., Olsen, A., Tjonneland, A., Bakken, K., Dumeaux, V., Lund, E., Jenab, M., Romieu, I., Michaud, D., Mouw, T., Carneiro, F., Fenge, C. & Riboli, E., 2012, In : Annals of Oncology. 23, 5, p. 1320-1324

    Research output: Contribution to journalArticle

  49. Power and limits of modern cancer diagnostics: cancer of unknown primary

    Kari Hemminki, Liu, H., Heminki, A. & Jan Sundquist, 2012, In : Annals of Oncology. 23, 3, p. 760-764

    Research output: Contribution to journalArticle

  50. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation

    Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Mikael Eriksson, Ruggieri, P., Daolio, P., Lindholm, P., Prete, A., Bisogno, G., Tamburini, A., Grignani, G., Abate, M. E., Podda, M., Smeland, S. & Ferrari, S., 2012, In : Annals of Oncology. 23, 11, p. 2970-2976

    Research output: Contribution to journalArticle

Previous 1 2 Next